All in for CTF: Jason Colodne and Colbeck Capital Support Children's Tumor Foundation Charity Poker Tournament
NEW YORK--(BUSINESS WIRE)--Colbeck Capital Management, a leading middle-market private credit firm focused on strategic lending, today announced its continued support of the Children's Tumor Foundation ('CTF' or the 'Foundation') through sponsorship of its 2025 New York City Charity Poker Tournament. The tournament, to be held June 12 at The Prince George Ballroom, invites participants to 'go all in' for the Children's Tumor Foundation and features a cocktail reception followed by Texas Hold 'Em tournament play.
All buy-ins, rebuys, sponsorships, and donations support the Foundation's mission to end neurofibromatosis and schwannomatosis (collectively known as NF), a group of genetic conditions that cause tumors to grow on nerves throughout the body. Support from Jason Colodne and Colbeck Capital helps drive research, expand knowledge, and advance care for individuals and families affected by NF.
Founded in 1978, the Children's Tumor Foundation is the drug discovery engine for NF. CTF brings treatments to patients faster by connecting doctors, scientists, pharmaceutical partners, and affected families with a mission to end NF. Through a patient-first, collaborative approach, CTF accelerates drug development and delivers life-changing therapies to individuals living with neurofibromatosis and schwannomatosis. To learn more about the event, please click here.
About Colbeck Capital Management
Colbeck Capital Management (colbeck.com) is a leading, middle-market private credit manager focused on strategic lending. Colbeck originates senior secured loans to companies going through periods of transition, providing creative capital solutions. Colbeck sponsors its portfolio companies through consistent engagement with management teams in areas such as finance, capital markets and growth strategies, distinguishing itself from traditional lenders. Colbeck was founded in 2009 by Jason Colodne and Jason Beckman and currently manages $3+ billion of invested and committed capital. Colbeck's principals have extensive experience investing through different market cycles at leading institutions, including Goldman Sachs and Morgan Stanley.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
16 hours ago
- Business Wire
All in for CTF: Jason Colodne and Colbeck Capital Support Children's Tumor Foundation Charity Poker Tournament
NEW YORK--(BUSINESS WIRE)--Colbeck Capital Management, a leading middle-market private credit firm focused on strategic lending, today announced its continued support of the Children's Tumor Foundation ('CTF' or the 'Foundation') through sponsorship of its 2025 New York City Charity Poker Tournament. The tournament, to be held June 12 at The Prince George Ballroom, invites participants to 'go all in' for the Children's Tumor Foundation and features a cocktail reception followed by Texas Hold 'Em tournament play. All buy-ins, rebuys, sponsorships, and donations support the Foundation's mission to end neurofibromatosis and schwannomatosis (collectively known as NF), a group of genetic conditions that cause tumors to grow on nerves throughout the body. Support from Jason Colodne and Colbeck Capital helps drive research, expand knowledge, and advance care for individuals and families affected by NF. Founded in 1978, the Children's Tumor Foundation is the drug discovery engine for NF. CTF brings treatments to patients faster by connecting doctors, scientists, pharmaceutical partners, and affected families with a mission to end NF. Through a patient-first, collaborative approach, CTF accelerates drug development and delivers life-changing therapies to individuals living with neurofibromatosis and schwannomatosis. To learn more about the event, please click here. About Colbeck Capital Management Colbeck Capital Management ( is a leading, middle-market private credit manager focused on strategic lending. Colbeck originates senior secured loans to companies going through periods of transition, providing creative capital solutions. Colbeck sponsors its portfolio companies through consistent engagement with management teams in areas such as finance, capital markets and growth strategies, distinguishing itself from traditional lenders. Colbeck was founded in 2009 by Jason Colodne and Jason Beckman and currently manages $3+ billion of invested and committed capital. Colbeck's principals have extensive experience investing through different market cycles at leading institutions, including Goldman Sachs and Morgan Stanley.
Business Wire
16-05-2025
- Business Wire
Colbeck Capital Supports World NF Awareness Day and the Children's Tumor Foundation
NEW YORK--(BUSINESS WIRE)--Colbeck Capital Management, a leading middle-market private credit firm focused on strategic lending, today announced its continued support of the Children's Tumor Foundation ('CTF' or the 'Foundation') in recognition of World NF Awareness Day which brings global attention to neurofibromatosis and schwannomatosis (collectively known as NF), a group of genetic conditions that cause tumors to grow on nerves throughout the body. World NF Awareness Day takes place annually on May 17 during NF Awareness Month, a dedicated time to elevate the inspirational and remarkable stories of those living with NF, and the critical need for research to better their lives. Through dedicated events and partner initiatives around the world, the Foundation is able to raise awareness and support to help change perceptions of the condition and strive for a cure. Support from Jason Colodne and Colbeck Capital are part of a matching opportunity designed to increase donations and inspire others to help drive research, expand knowledge, and advance care for the NF community. Founded in 1978, the Children's Tumor Foundation is the drug discovery engine for NF. CTF brings treatments to patients faster by connecting doctors, scientists, pharmaceutical partners, and affected families with a mission to end NF. Through a patient-first, collaborative approach, CTF accelerates drug development and delivers life-changing therapies to individuals living with neurofibromatosis and schwannomatosis. To learn more about the foundation, please click here. About Colbeck Capital Management Colbeck Capital Management ( is a leading, middle-market private credit manager focused on strategic lending. Colbeck originates senior secured loans to companies going through periods of transition, providing creative capital solutions. Colbeck sponsors its portfolio companies through consistent engagement with management teams in areas such as finance, capital markets and growth strategies, distinguishing itself from traditional lenders. Colbeck was founded in 2009 by Jason Colodne and Jason Beckman and currently manages $3+ billion of invested and committed capital. Colbeck's principals have extensive experience investing through different market cycles at leading institutions, including Goldman Sachs and Morgan Stanley.
Yahoo
06-05-2025
- Yahoo
Thought Technology Ltd. Continues Its Tradition of Supporting the AAPB Conference with World-Class Biofeedback Solutions and a Poker-Themed Exhibitor Demo
MONTREAL, May 6, 2025 /PRNewswire/ -- Thought Technology Ltd., a global leader in biofeedback instrumentation, is proud to once again exhibit at the Association for Applied Psychophysiology and Biofeedback (AAPB) Annual Conference, taking place May 14-17, 2025 in San Diego. Thought Tech As a long-time supporter of AAPB's mission, Thought Technology remains dedicated to advancing the field of psychophysiology through innovative tools that empower professionals and individuals alike. At this year's event, Thought Technology will spotlight how its products can be used in settings where group dynamics play a role, such as family therapy sessions, couples counselling and team building activities, providing a way to strengthen the group by harnessing each individual's physiology. They'll have a bit of fun with this concept on Saturday, May 17th, when they will host a Texas Hold'em themed exhibitor demo. This engaging demonstration will illustrate how one's physiology can reveal their thoughts and emotions. While seasoned poker players rely on controlling their expressions and body language to keep opponents guessing, their physiology might tell a different story. The eVu-TPS sensor and BioGraph Infiniti Synergy Suite can track subtle changes in heart rate, skin conductance, and temperature—offering insight into the pressure players feel in real time. Even if they keep a perfect poker face, the physiological data could indicate signs of stress or excitement. The real challenge will be whether players can manage their autonomic responses as effectively as they control their outward expressions. Additionally, on Wednesday, May 14, 2025, Thought Technology's Technical Support Director, Frank DeGregorio, will lead a pre-conference workshop on Patient Intervention through the Use of Biofeedback Trainings with a Variety of Physiological Peripherals, offering hands-on training in the use of their biofeedback instrumentation. This interactive session will feature practical demonstrations and expert guidance, equipping attendees—whether new to biofeedback or experienced practitioners—with the knowledge and skills to effectively implement Thought Technology's clinical solutions in their practice. Conference attendees are invited to visit Thought Technology at booth #8 to experience live demonstrations of their range of products, test the equipment firsthand, and gain valuable insights into how they can make the most of these innovative tools for optimizing wellness and performance. "For years, the AAPB Conference has provided an invaluable platform for collaboration, learning, and innovation, and we're honored to be part of this annual gathering once again," said Helen Mavros, Sales and Marketing Director at Thought Technology Ltd. "Our robust line of biofeedback solutions reflects our ongoing commitment to supporting practitioners and the clients they serve in harnessing the power of physiological awareness."
